echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Pfizer submitted an application to the FDA for an upgraded vaccine for people aged 5 to 11 years

    Pfizer submitted an application to the FDA for an upgraded vaccine for people aged 5 to 11 years

    • Last Update: 2022-10-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Pfizer submitted an application authorization
    to the US Food and Drug Administration (FDA) on the 26th local time for the vaccination of Pfizer upgraded version of the new crown vaccine for groups aged 5 to 11.
     
    The upgraded vaccine that Pfizer applied for authorization is a vaccine developed for the Omikron variant BA.
    5
    .
    According to US media reports, Pfizer has not yet released human trial data
    for the upgraded version of the vaccine.
     
    Pfizer issued a statement on the same day that the data submitted for the application was based on previous human trial data on the Omicrane variant BA.
    1 vaccine and animal test data
    on the BA.
    5 vaccine.
     
    On August 31, the FDA approved the Modener and Pfizer upgraded COVID-19 vaccines against the Omikron strain
    .
    The public can be vaccinated at least two months after the completion of the initial vaccine or booster
    vaccination.
    The upgraded Modena vaccine is for people aged 18 years and older, and the upgraded Pfizer vaccine is for people aged 12 years and older
    .
     
    On the 23rd of this month, the American company Modena has submitted an application authorization to the FDA for the vaccination of the Modena upgraded new crown vaccine for the 6 to 17-year-old group
    .
     
    According to a document recently released by the US Centers for Disease Control and Prevention (CDC), the upgraded COVID-19 vaccine for children aged 5 and over will likely be approved
    in October.
     
    According to the CDC, 4.
    4 million Americans have been vaccinated
    since the upgraded COVID-19 vaccine was approved.
    Experts believe that the upgraded COVID-19 vaccine will play a role in preventing the spread of the epidemic this autumn and winter, targeting the leading strain that is currently spreading
    .
     
    According to the latest statistics from Johns Hopkins University in the United States, as of 19:00 on the 26th, the cumulative number of confirmed covid-19 cases in the United States exceeded 96.
    1 million, and the number of deaths exceeded 1.
    056 million
    .
    (End)
    Pfizer submitted an application authorization
    to the US Food and Drug Administration (FDA) on the 26th local time for the vaccination of Pfizer upgraded version of the new crown vaccine for groups aged 5 to 11.
     
    The upgraded vaccine that Pfizer applied for authorization is a vaccine developed for the Omikron variant BA.
    5
    .
    According to US media reports, Pfizer has not yet released human trial data
    for the upgraded version of the vaccine.
     
    Pfizer issued a statement on the same day that the data submitted for the application was based on previous human trial data on the Omicrane variant BA.
    1 vaccine and animal test data
    on the BA.
    5 vaccine.
     
    On August 31, the FDA approved the Modener and Pfizer upgraded COVID-19 vaccines against the Omikron strain
    .
    The public can be vaccinated at least two months after the completion of the initial vaccine or booster
    vaccination.
    The upgraded Modena vaccine is for people aged 18 years and older, and the upgraded Pfizer vaccine is for people aged 12 years and older
    .
     
    On the 23rd of this month, the American company Modena has submitted an application authorization to the FDA for the vaccination of the Modena upgraded new crown vaccine for the 6 to 17-year-old group
    .
     
    According to a document recently released by the US Centers for Disease Control and Prevention (CDC), the upgraded COVID-19 vaccine for children aged 5 and over will likely be approved
    in October.
    Diseases and diseases of children in children
     
    According to the CDC, 4.
    4 million Americans have been vaccinated
    since the upgraded COVID-19 vaccine was approved.
    Experts believe that the upgraded COVID-19 vaccine will play a role in preventing the spread of the epidemic this autumn and winter, targeting the leading strain that is currently spreading
    .
     
    According to the latest statistics from Johns Hopkins University in the United States, as of 19:00 on the 26th, the cumulative number of confirmed covid-19 cases in the United States exceeded 96.
    1 million, and the number of deaths exceeded 1.
    056 million
    .
    (End)
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.